Discover how Uganda is tackling prostate cancer through expert consensus and research prioritization using the Delphi method.
Exploring how genetically engineered Newcastle disease virus is being developed as a potential treatment for prostate cancer through oncolytic virotherapy.
Exploring how endosomal recycling inhibitors downregulate the androgen receptor and synergize with enzalutamide in prostate cancer treatment.
Exploring how a failed prostate cancer trial with mitomycin C and estramustine led to better targeted treatments for hormone-resistant metastatic prostate cancer.
Discover how the 28-day Prostate Cancer Patient Empowerment Program (PC-PEP) is transforming prostate cancer recovery through digital innovation and patient-centered care.
Research reveals how prostate cancer treatment impacts spouses' quality of life 36 months post-treatment, highlighting caregiver appraisal and relationship dynamics.
Learn about a novel risk stratification tool that helps optimize patient selection for salvage lymph node dissection in prostate cancer recurrence.
Exploring how prostate cancer impacts identity, faith, and cultural belonging among Jordanian Muslim men through groundbreaking research.
Exploring the potential of simultaneous androgen and estrogen receptor blockade in prostate cancer treatment using natural compounds like carnosol.